CUBIST PHARMACEUTICALS INC
CBST
CBST was delisted on the 21st of January, 2015.
307 hedge funds and large institutions have $8B invested in CUBIST PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 66 increasing their positions, 90 reducing their positions, and 68 closing their positions.
483% more funds holding in top 10
Funds holding in top 10: 6 → 35 (+29)
82% more first-time investments, than exits
New positions opened: 124 | Existing positions closed: 68
51% more capital invested
Capital invested by funds: $5.31B → $8B (+$2.69B)
21% more funds holding
Funds holding: 254 → 307 (+53)
27% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 90
54% less call options, than puts
Call options by funds: $329M | Put options by funds: $708M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
HBK Investments
Dallas,
Texas
|
+$222M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$201M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$199M |
| 4 |
EPCM
Eton Park Capital Management
New York
|
+$148M |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
+$127M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$477M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$312M |
| 3 |
Bank of New York Mellon
New York
|
-$280M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$250M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$156M |
CBST Hedge Fund Activity: Q4 2014 in Review
307 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q4 2014, worth a combined $8B — up 51% from $5.31B a quarter earlier.
Buyers outnumbered sellers: 124 funds opened new CBST positions and 68 closed out — a net gain of 56 holders — while 66 added to existing stakes and 90 trimmed.
The largest buyer was HBK Investments, opening a new position worth an estimated $222M. The largest seller was Putnam Investments, cutting an estimated $477M.
- 307 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q4 2014, up from 254 in Q3 2014.
- Funds reported $8B of CUBIST PHARMACEUTICALS INC stock for Q4 2014, up 51% quarter-over-quarter.
- 124 funds opened new CUBIST PHARMACEUTICALS INC positions in Q4 2014 and 68 closed out, a net change of +56 holders.
- The largest CUBIST PHARMACEUTICALS INC buyer in Q4 2014 was HBK Investments, an estimated $222M added.
- The largest CUBIST PHARMACEUTICALS INC seller in Q4 2014 was Putnam Investments, an estimated $477M sold.
Based on aggregated 13F filings for Q4 2014.